Human immunodeficiency virus (HIV) remains a formidable global health challenge, recognized as the third most widespread epidemic worldwide. It imposes a particularly heavy burden on lower-middle-income countries (LMICs) like India, where healthcare resources are often limited. Despite concerted efforts and notable progress at the national level, the prevalence of HIV among adults aged 15-49 years continues to be a significant public health issue. As of the latest estimates, approximately 24 lakh individuals in India are living with HIV (PLHIV). The sustained high numbers underscore the enduring challenge of HIV management and control in the country.1-4
A positive development has been the decline in the rate of annual new infections (ANI), which has shown a 46.3% reduction from 2010 to 2021. In 2021, the ANI was estimated to be around 62.97 thousand. This downward trend is a testament to the effectiveness of various public health interventions and awareness programs aimed at curbing the spread of the virus. However, this decline is not uniform across all states, with some regions demonstrating more significant progress than others. Notably, Himachal Pradesh, Tamil Nadu, and Telangana have recorded the most substantial reductions in ANI, with declines of 73%, 72%, and 71%, respectively. These statistics highlight the success of targeted intervention strategies in these states, offering valuable lessons for other regions.5-8
Despite these advances, the challenge remains complex due to the diverse modes of HIV transmission, varying levels of awareness and education, and the presence of co-infections such as tuberculosis (TB), which complicates treatment and management. Tuberculosis, especially in its extra-pulmonary form, is a common co-infection among HIV-positive individuals, exacerbating the disease burden and complicating clinical outcomes. Understanding the interplay between HIV and TB is crucial for developing effective treatment protocols and improving patient outcomes.8-10
This study aims to provide a comprehensive epidemiological and microbiological profile of the HIV seropositive population in a tertiary care hospital in Shimla, Himachal Pradesh. By focusing on the demographics, modes of transmission, co-infection with tuberculosis, and the impact of antiretroviral therapy (ART) on this population, we aim to uncover critical insights that can inform public health strategies and clinical practices. This retrospective analysis will shed light on the current state of HIV in this specific setting, offering a detailed understanding of the challenges and opportunities for improving HIV care and management.
Study Design
A retrospective study was carried out at the Integrated Counseling and Testing Centre (ICTC) of Indira Gandhi Medical College (IGMC), Shimla, spanning from January 2021 to December 2021. This study aimed to delineate the epidemiological and microbiological characteristics of the HIV seropositive population within this tertiary care setting.
Study Population
The study population consisted of 57 patients who had been diagnosed with HIV during the study period. These patients were selected based on their attendance at the ICTC for diagnostic and therapeutic services.
Data Collection
Data were meticulously collected from the patients' medical records, focusing on the following variables:
Demographics
The demographic data encompassed:
Age: Stratification of patients into various age groups to understand the distribution of HIV across different stages of life.
Sex: Analysis of the male to female ratio to identify gender-specific prevalence.
Occupation: Categorization of patients based on their occupational status, including housewives, government/private service employees, laborers, drivers, self-employed individuals, skilled workers, hotel staff, students, and unspecified professions.
Educational Qualification: Classification based on the highest level of education completed, including primary school, secondary school, higher secondary, college, and illiteracy.
Marital Status: Recording of patients' marital status to explore any correlations with HIV transmission and management.
Modes of Transmission
The study explored the various routes through which HIV was transmitted among the patients:
Heterosexual Transmission: Documenting cases where HIV was acquired through heterosexual contact.
Homosexual Transmission: Identifying instances of HIV transmission through homosexual contact.
Infected Syringes and Needles: Recording cases where transmission occurred via the use of contaminated syringes and needles.
Mother-to-Child Transmission: Noting cases of vertical transmission from mother to child.
Unknown Routes: Instances where the route of transmission could not be determined.
Co-infection with Tuberculosis
Given the significant co-morbidity of tuberculosis (TB) with HIV, data were collected on the presence or absence of TB among the patients:
Pulmonary Tuberculosis: Cases where TB infection was localized to the lungs.
Extra-pulmonary Tuberculosis: Instances where TB infection occurred in sites other than the lungs.
Antiretroviral Therapy (ART)
The study also focused on the management of HIV through ART:
Proportion of Patients on ART: Recording the percentage of patients who had commenced ART.
CD4 Count at Diagnosis: Measuring the CD4 cell counts at the time of diagnosis to assess the immune status of the patients.
Viral Load Status: Determining the viral load in patients, categorized as undetectable, low, or high.
Data Analysis
The collected data were analyzed using descriptive statistics. This approach facilitated the summarization of key findings, providing insights into the epidemiological and clinical characteristics of the HIV seropositive population in the study. The analysis included the calculation of frequencies, percentages, and mean values to present a comprehensive profile of the patients.
The study revealed significant insights into the demographics, modes of transmission, co-infection with tuberculosis, and the impact of antiretroviral therapy (ART) among the HIV seropositive population in a tertiary care hospital in Shimla.
The age distribution of the patients indicated that the majority (80.7%) were between the ages of 15 to 49 years, highlighting that HIV predominantly affects the economically productive and reproductive age group. This demographic finding underscores the need for targeted interventions and awareness programs aimed at this age group to effectively curb the spread of HIV. The sex ratio showed a male to female ratio of 1.8:1, indicating a male preponderance in HIV infection. This suggests the presence of gender-specific factors influencing the risk and transmission of HIV, necessitating tailored strategies to address the unique vulnerabilities and behaviors of both men and women.
Occupational history varied among the patients, reflecting diverse socio-economic backgrounds. The distribution was as follows: 30% were housewives, 18% were in government/private service, 14% were laborers, 11% were drivers, 9% were self-employed, 7% were skilled workers, 5% worked in hotels, 3% were students, and 3% did not specify their profession. This occupational diversity indicates that HIV impacts individuals across various sectors, emphasizing the need for widespread workplace education and preventive measures.
Regarding educational qualification, 42% of the patients completed secondary school, 28% completed primary school, 14% were not literate, 11% completed higher secondary, and 5% completed college. These figures suggest that while a majority had some level of education, a significant portion had limited or no formal education. This variation in educational attainment highlights the importance of health education programs tailored to different literacy levels to effectively disseminate HIV prevention and treatment information.
Sexual transmission was identified as the predominant route of HIV acquisition. Among these cases, 97.29% were transmitted through heterosexual contact, while 2.7% were through homosexual contact. The overwhelming prevalence of heterosexual transmission indicates the critical need for targeted sexual health education and the promotion of safe sex practices to reduce the spread of HIV through sexual contact. Other modes of transmission included infected syringes and needles (7%), mother-to-child transmission (1.7%), and unknown routes (26.3%). The relatively high percentage of unknown transmission routes points to gaps in patient history taking or reporting, necessitating improved data collection and patient education to better understand and address these unidentified risks.
The study found that 12.2% of the patients were co-infected with tuberculosis (TB), highlighting the significant overlap between HIV and TB infections. Among those co-infected with TB, 71.4% had extra-pulmonary tuberculosis. The predominance of extra-pulmonary TB in HIV patients underscores the need for vigilant screening and early diagnosis of TB in HIV-positive individuals to manage and treat this co-morbidity effectively.
A total of 88% of the patients commenced antiretroviral therapy (ART), reflecting a high rate of treatment uptake, which is crucial for managing HIV and improving patient outcomes. However, 12% of the patients died before starting ART, with 29% of these deaths attributable to HIV-TB co-infection. This highlights the urgent need for early diagnosis and prompt initiation of ART to reduce mortality rates among HIV patients. The mean CD4 count at diagnosis was 255 cells/mm³, with a range from 17 to 845 cells/mm³. This indicates that many patients were diagnosed at advanced stages of HIV infection, emphasizing the need for earlier testing and intervention to improve immune function and patient outcomes. Viral load analysis showed that 79% of patients had an undetectable viral load, 18% had a low viral load, and 3% had a high viral load. The high proportion of patients with undetectable viral loads suggests effective management and treatment among those on ART. However, the presence of low and high viral loads in a minority of patients indicates ongoing challenges in achieving optimal viral suppression for all individuals.
Table 1: Demographic and Clinical Characteristics of Study Population
Characteristic | Category | Number/Percentage |
Age Group (Years) | 0-10 | 1 |
11-20 | 2 | |
21-30 | 9 | |
31-40 | 18 | |
41-50 | 19 | |
51-60 | 8 | |
Sex Ratio | Male | 1.8:1 |
Mode of Transmission | Heterosexual | 97.29% |
Homosexual | 2.7% | |
Infected syringes and needles | 7% | |
Mother-to-child | 1.7% | |
Unknown | 26.3% | |
Occupation | Housewives | 30% |
Government/Private Service | 18% | |
Laborers | 14% | |
Drivers | 11% | |
Self-employed | 9% | |
Skilled workers | 7% | |
Hotel workers | 5% | |
Students | 3% | |
Not specified | 3% | |
Educational Background | Secondary school | 42% |
Primary school | 28% | |
Not literate | 14% | |
Higher secondary | 11% | |
College | 5% | |
TB Co-infection | Co-infected with TB | 12.2% |
Extra-pulmonary TB | 71.4% | |
ART Initiation | On ART | 88% |
Mortality Before ART | Died before starting ART | 12% |
Deaths due to HIV-TB co-infection | 29% | |
CD4 Count at Diagnosis | Mean (Range) | 255 cells/mm³ (17-845 cells/mm³) |
Viral Load | Undetectable | 79% |
Low | 18% | |
High | 3% |
The findings of this study provide critical insights into the epidemiological trends and clinical challenges encountered by the HIV seropositive population in a tertiary care hospital in Shimla. The data revealed a predominant mode of HIV transmission through heterosexual contact, accounting for 97.29% of cases. This finding is consistent with national trends and underscores the importance of targeted interventions in sexual health education and the promotion of safe sexual practices. There is a pressing need to enhance public awareness about HIV transmission routes and preventive measures to reduce the incidence of new infections. Educational campaigns should be tailored to reach diverse demographic groups, emphasizing the importance of safe sex practices and regular HIV testing.11,12
A notable proportion of patients (26.3%) had an unknown route of transmission. This significant percentage indicates gaps in patient awareness or accurate reporting of transmission modes. It highlights the necessity for comprehensive counseling and education programs that address these knowledge gaps. Healthcare providers should be trained to obtain thorough patient histories and provide clear, accurate information about all possible transmission routes. Such initiatives can help in the accurate tracking of infection sources and improve the effectiveness of preventive strategies.10-12
The co-infection with tuberculosis (TB), particularly extra-pulmonary TB, was another critical finding of this study. Among the co-infected patients, 71.4% had extra-pulmonary TB, emphasizing the intricate relationship between HIV and TB infections. This intersection of HIV and TB poses significant diagnostic and therapeutic challenges. Extra-pulmonary TB is often more difficult to diagnose and treat, requiring heightened vigilance and comprehensive screening protocols in HIV-positive individuals. Early detection and treatment of TB in HIV-infected patients are crucial to managing this dual burden and improving patient outcomes.13-15
The study also highlighted a concerning high mortality rate among patients who did not start antiretroviral therapy (ART). Specifically, 12% of patients died before initiating ART, with 29% of these deaths attributed to HIV-TB co-infection. This finding underscores the urgent need for early diagnosis and prompt initiation of ART. Delayed treatment initiation leads to worse health outcomes and higher mortality rates. Therefore, healthcare systems must prioritize rapid linkage to care and ART initiation for newly diagnosed HIV patients. Streamlined processes for diagnosis, counseling, and treatment initiation can significantly reduce mortality rates and improve the quality of life for HIV-positive individuals.16-18
The mean CD4 count at diagnosis was 255 cells/mm³, with a range from 17 to 845 cells/mm³, indicating that many patients were diagnosed at advanced stages of HIV infection. This relatively low CD4 count at diagnosis highlights the need for earlier testing and intervention. Patients presenting with advanced HIV disease are at higher risk for opportunistic infections and other complications. Increasing access to early HIV testing and encouraging routine screening, particularly in high-risk populations, can facilitate earlier diagnosis and timely initiation of ART. Community-based testing initiatives and mobile clinics can play a pivotal role in reaching underserved populations and reducing barriers to testing.18,19
The viral load analysis revealed that 79% of patients had undetectable viral loads, suggesting effective management and treatment among those on ART. However, 18% had low viral loads, and 3% had high viral loads, indicating ongoing challenges in achieving optimal viral suppression for all individuals. This variability in viral load underscores the need for continuous monitoring and individualized patient management. Ensuring adherence to ART and addressing factors that contribute to treatment failure, such as drug resistance or social determinants of health, are essential components of comprehensive HIV care.20-22
This study highlights the multifaceted challenges faced by the HIV seropositive population in Shimla. Addressing these challenges requires a multifaceted approach, including enhanced public education, comprehensive counseling, early diagnosis, timely ART initiation, and continuous patient monitoring. By implementing targeted interventions and improving healthcare delivery systems, we can better manage HIV and co-infections, ultimately improving the health outcomes and quality of life for those affected by HIV.
The study highlights that heterosexual transmission remains the predominant mode of HIV transmission among the population, with a notable male preponderance. The significant presence of extra-pulmonary tuberculosis in HIV-TB co-infected patients underscores the need for vigilant screening and early intervention. To improve outcomes, it is crucial to enhance grassroots awareness, implement aggressive case-finding strategies in high-risk populations, and ensure robust cross-referral systems for early detection and management of dual infections. These measures are essential for reducing the burden of HIV and co-infections, ultimately improving patient health and quality of life.
Ray I, Hasan MM, Shah PA, Sahito AM, Sarkar A, Ghosh D, et al. HIV epidemic amidst COVID-19 pandemic in India: a conundrum for the country's healthcare system. Epidemiol Infect. 2022 May 26;150
Shao Y, Williamson C. The HIV-1 epidemic: low- to middle-income countries. Cold Spring Harb Perspect Med. 2012 Mar;2(3).
World Health Organization. HIV/AIDS [Internet]. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids
The World Bank. HIV/AIDS in India [Internet]. Available from: https://www.worldbank.org/en/news/feature/2012/07/10/hiv-aids-india
National AIDS Control Organization. India HIV Estimates 2021 Fact Sheet [Internet]. Available from: https://naco.gov.in/sites/default/files/India%20HIV%20Estimates%202021%20_Fact%20Sheets__Final_Shared_24_08_2022_0.pdf
North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences. HIV & AIDS Policy -2023 [Internet]. Available from: https://neigrihms.gov.in/Latest%20News/DDA/2023/Final%20HIV%20_%20AIDS%20Policy%202023.pdf
Shri N, Bhattacharyya K, Dhamnetiya D, Singh M, Jha RP, Patel P. Long-term trends of HIV/AIDS incidence in India: an application of joinpoint and age-period-cohort analyses: a gendered perspective. Front Public Health. 2023 May 16;11:1093310.
Malik M, Girotra S, Roy D, Basu S. Knowledge of HIV/AIDS and its determinants in India: Findings from the National Family Health Survey-5 (2019–2021). Popul Med. 2023;5(May):13.
Qi CC, Xu LR, Zhao CJ, et al. Prevalence and risk factors of tuberculosis among people living with HIV/AIDS in China: a systematic review and meta-analysis. BMC Infect Dis. 2023;23:584.
Heidary M, Shirani M, Moradi M, Goudarzi M, Pouriran R, Rezaeian T, et al. Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment. Eur J Microbiol Immunol (Bp). 2022 Apr 14;12(1):1–17.
Kumah E, Boakye DS, Boateng R, Agyei E. Advancing the Global Fight Against HIV/Aids: Strategies, Barriers, and the Road to Eradication. Ann Glob Health. 2023 Nov 27;89(1):83.
Pettifor A, Bekker LG, Hosek S, DiClemente R, Rosenberg M, Bull SS, et al. Preventing HIV among young people: research priorities for the future. J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2(0 2).
Yang Q, Han J, Shen J, Peng X, Zhou L, Yin X. Diagnosis and treatment of tuberculosis in adults with HIV. Medicine (Baltimore). 2022 Sep 2;101(35).
Giri PA, Deshpande JD, Phalke DB. Prevalence of Pulmonary Tuberculosis Among HIV Positive Patients Attending Antiretroviral Therapy Clinic. N Am J Med Sci. 2013 Jun;5(6):367-70.
Gopalaswamy R, Dusthackeer VNA, Kannayan S, Subbian S. Extrapulmonary Tuberculosis—An Update on the Diagnosis, Treatment and Drug Resistance. J Respir. 2021;1(2):141-64.
Benson C, Emond B, Romdhani H, Lefebvre P, Côté-Sergent A, Shohoudi A, et al. Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency Virus. J Manag Care Spec Pharm. 2020 Feb;26(2):117-28.
Tao Y, Xiao X, Zhang C, Xie Y, Wang H. Prevalence of delayed antiretroviral therapy initiation among people living with HIV: A systematic review and meta-analysis. PLoS One. 2023 Oct 24;18(10).
Hung CC, Phanuphak N, Wong CS, Olszyna DP, Kim TH. Same-day and rapid initiation of antiretroviral therapy in people living with HIV in Asia. How far have we come? HIV Med. 2022;23(Suppl 4):3-14.
Gandhi RT, Bedimo R, Hoy JF, et al. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society–USA Panel. JAMA. 2023;329(1):63–84.
Chandane Tak M, Vaidyanathan A, Mukherjee A. Revolutionizing HIV-1 Viral Load Monitoring in India: The Potential of Dried Blood Spot Analysis for Expanding Access and Improving Care. Healthcare (Basel). 2024 Feb 6;12(4):413.
World Health Organization. HIV drug resistance [Internet]. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-drug-resistance
Gumede SB, Wensing AMJ, Lalla-Edward ST, de Wit JBF, Francois Venter WD, Tempelman HA, et al. Predictors of Treatment Adherence and Virological Failure Among People Living with HIV Receiving Antiretroviral Therapy in a South African Rural Community: A Sub-study of the ITREMA Randomised Clinical Trial. AIDS Behav. 2023 Dec;27(12):3863-85.